The IPA World Congress + Probiota 2023 is two months away! The leading event for the probiotics, prebiotics, and microbiome community is a must-attend event, and let us tell you why…
The gut-organ axis is a key innovation opportunity for probiotics, according to Health and Happiness Group (H&H Group) – the company behind health supplement brand Swisse and infant nutrition products Biostime.
Future infant nutrition research should look into the link between nutrients and gut-brain axis and even its impacts decades later when a child reaches adulthood, instead of merely mimicking human breast milk and focusing on only height and weight gain.
The landscape of the probiotics industry has changed drastically in recent years, with more firms creating products that seek to improve a wide variety of health conditions, aside from gut health.
Probiotics may not be as effective as non-probiotic methods of intestinal microbiota regulation when it comes to relieving anxiety symptoms, according to a Chinese systematic review.
Australian brand Uplift Food is seeking to expand its range of products for gut health and cognitive function, basing its formulations on the emerging science of psychobiotics.
Out of 11,018 studies conducted on neurological diseases, only 23 examined the effects of probiotics on the diseases. This was less than 1% of all studies done, a review of clinical studies has found.
The mechanisms behind the gut-brain axis in infants should be further explored and better understood, so possible nutritional interventions can be explored to support healthy brain development, according to a Danone-led study.
